Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 252721 - 252740 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Greece | (M05BX04) denosumab (adm: P) | XGEVA INJ.SO.PFS 120MG/ML BT X 1 P.F.SYR X 1 ML WITH AUTOMATIC NEEDLE COVERING MECHANISM | n/a | Retail price with vat |
$0-0 |
$0-0 |
Giant Cell Tumor of Bone;Neoplasms, Bone Tissue | AMGENEUROPEBV,BREDA,HOLLAND |
| Greece | (M05BX04) denosumab (adm: P) | XGEVA INJ.SOL 120MG/1,7ML (70MG/ML) BTx1VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Giant Cell Tumor of Bone;Neoplasms, Bone Tissue | AMGENEUROPEBV,BREDA,HOLLAND |
| Greece | (M05BX04) denosumab (adm: P) | PROLIA INJ.SOL 60MG/ML 1 PF.SYR με αυτόματο μηχανισμό κάλυψης βελόνας σε BLISTER | n/a | Retail price with vat |
$0-0 |
$0-0 |
Bone Resorption;Osteoporosis, Postmenopausal;Osteoporosis | AMGENEUROPEBV,BREDA,HOLLAND |
| Greece | (M05BX05) burosumab (adm: P) | CRYSVITA INJ.SOL 10MG/ML VIAL VIAL X 1ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KYOWAKIRINHOLDINGSB.V.,THENETHERLANDS |
| Greece | (M05BX05) burosumab (adm: P) | CRYSVITA INJ.SOL 20MG/ML VIAL VIAL X 1ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KYOWAKIRINHOLDINGSB.V.,THENETHERLANDS |
| Greece | (M05BX05) burosumab (adm: P) | CRYSVITA INJ.SOL 30MG/ML VIAL VIAL X 1ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KYOWAKIRINHOLDINGSB.V.,THENETHERLANDS |
| Greece | (M05BX06) romosozumab (adm: P) | EVENITY IN.SO.PF.P 105MG/1.17ML (90MG/ML) 2PF. PENSx 1.17 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Osteoporosis | UCBPHARMAS.A.,BELGIUM |
| Greece | (M09AX07) nusinersen (adm: P) | SPINRAZA INJ.SOL 12MG/VIAL BTx1 VIAL x 5ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | BIOGENNETHERLANDSB.V.,THENETHERLANDS |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 10 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 11 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 12 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 13 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 2 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 3 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 4 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 5 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 6 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 7 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 8 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 9 VIALS x 8.3 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NOVARTISEUROPHARMLIMITED,IRELAND |
Pages
